Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an increased risk of prosthesis-patient mismatch (PPM), which correlates with a higher incidence of heart failure and mortality. However, there are no medium- or long-term follow-up studies on this topic.

Evolución de las válvulas balón expandibles pequeñas

Researchers conducted an analysis on 316,091 patients in the TVT Registry who received SAPIEN 3, SAPIEN 3 Ultra, or SAPIEN 3 Ultra RESILIA balloon-expandable valves, comparing those who received 20-mm valves with those who received 23-, 26-, or 29-mm valves.

Due to group heterogeneity, propensity score matching was performed. As a result, each group included 8100 patients.

After implantation, patients with small ring showed a higher incidence of gradient ≥20 mmHg (26.4% vs. 6.9%; p <0.0001), a lower indexed effective aortic area (0.8±0.3 vs. 1±0.3; p <0.0001), higher severe PPM (20% vs. 8.2%; p <0.0001), and a greater risk of moderate or severe paravalvular leak (1.8% vs. 0.5%; p <0.0001). Ring rupture was less frequent in patients with small ring, with no differences regarding major vascular complications or life-threatening bleeding.

At the 30-day and one-year follow-up, there were no differences in all-cause mortality, stroke, bleeding, or readmission. The need for pacemaker was lower in patients with small ring at both 30 days and one year (4.8% vs. 8.5%; p <0.0001 and 5.8% vs. 9.8%; p <0.0001, respectively). However, researchers observed a trend toward a higher reintervention rate in this group (0.6% vs. 0.2%; p = 0.0005).

Read also: TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions.

At 3 years of follow-up, there were no differences in the composite outcome of all-cause mortality or stroke. However, severe PPM was associated with higher mortality compared to patients with moderate or no PPM.

Patients with mean gradient <10 mmHg and ejection fraction <50%, as well as those with mean gradient >30 mmHg, showed higher mortality at 3 years of follow-up.

In a multivariate analysis, mortality was associated with moderate or severe paravalvular leak, as well as with mean gradient <10 mmHg or >30 mmHg at follow-up.

Conclusion

Patients who received a small (20 mm) balloon-expandable valve had comparable three-year survival rates to those who received 23-mm valves or larger. However, severe PPM and gradient <10 mmHg, associated with a low ejection fraction, were linked to higher mortality, suggesting that low ejection fraction may be the determining factor in unfavorable outcomes.

Original Title: 3-Year Outcomes of Balloon-Expandable Valves 20-mm vs Larger Valves (>23 mm).

Reference: Marvin H. Eng, et al. JACC Cardiovasc Interv. 2024;17:2041–2051.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Carlos Fava
Dr. Carlos Fava
Member of the Editorial Board of solaci.org

More articles by this author

TCT 2024 | Asymptomatic Severe Aortic Stenosis: What Should Be our Approach?

Approximately 3% of the population over 65 years old has aortic stenosis. Current guidelines recommend valve replacement for patients with symptoms or an ejection...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | Asymptomatic Severe Aortic Stenosis: What Should Be our Approach?

Approximately 3% of the population over 65 years old has aortic stenosis. Current guidelines recommend valve replacement for patients with symptoms or an ejection...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...